Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
- April - May - June - July - August - September - Oktober - November - December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
- 2025
January 2025 - 72 products
L
IP
CI
Bosutinib Spirig HC 100 mg
28
334.95
380.70
10 %
Coated tablets: Bosutinibum 100 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Bosutinib Spirig HC 400 mg
28
1339.80
1473.55
10 %
Coated tablets: Bosutinibum 400 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Bosutinib Spirig HC 500 mg
28
1578.82
1733.50
10 %
Coated tablets: Bosutinibum 500 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
CI
Ticagrelor axapharm 60 mg
56
20.48
38.70
10 %
Coated tablets: Ticagrelorum 60 mg
axapharm ag
B / SL / SG
FB
G
L
IP
CI
Ticagrelor axapharm 60 mg
168
61.43
83.20
10 %
Coated tablets: Ticagrelorum 60 mg
axapharm ag
B / SL / SG
FB
G
L
IP
Ticagrelor axapharm 90 mg
56
23.69
42.20
10 %
Coated tablets: Ticagrelorum 90 mg
axapharm ag
B / SL / SG
FB
G
L
IP
Ticagrelor axapharm 90 mg
98
41.47
61.55
10 %
Coated tablets: Ticagrelorum 90 mg
axapharm ag
B / SL / SG
FB
G
L
IP
Ticagrelor axapharm 90 mg
168
71.09
93.75
10 %
Coated tablets: Ticagrelorum 90 mg
axapharm ag
B / SL / SG
FB
G
Doxorubicin Accord
liposomal 20 mg/10 ml
PR
PR
k.A.
Accord Healthcare AG
A
FB
G
Doxorubicin Accord
liposomal 50 mg/25 ml
PR
PR
k.A.
Accord Healthcare AG
A
FB
G
Zoledronat Onco Labatec, 4
mg/100 ml
100 ml
PR
PR
k.A.
Infusion solution: Acidum Zoledronicum 4mg / 100ml
Labatec Pharma SA
B
FB
G
Wyost 120 mg/ 1.7 ml
PR
PR
k.A.
Injection solution: Denosumabum 120 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Jubbonti 60 mg/ml
PR
PR
k.A.
Injection solution in prefilled syringe: Denosumabum 60 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Voxzogo 0.4 mg
10
PR
PR
k.A.
Lyophilisate and solvent: Vosoritidum
DRAC AG
A
FB
G
Voxzogo 0.56 mg
10
PR
PR
k.A.
Lyophilisate and solvent: Vosoritidum
DRAC AG
A
FB
G
Voxzogo 1.2 mg
10
PR
PR
k.A.
Lyophilisate and solvent: Vosoritidum 1.2 mg
DRAC AG
A
FB
G
Cefepime OrPha 1 g
10
PR
PR
k.A.
Dry substance: Cefepimum 1000 mg
OrPha Swiss GmbH
A
FB
G
Cefepime OrPha 2 g
10
PR
PR
k.A.
Dry substance: Cefepimum 2000 mg
OrPha Swiss GmbH
A
FB
G
IP
CI
Opzelura 15 mg/g
100 g
PR
PR
k.A.
Cream: Ruxolitinibum 15 mg
Incyte Biosciences
International Sàrl
B
FB
G
IP
CI
Opzelura 15 mg/g
100 g
PR
PR
k.A.
Cream: Ruxolitinibum 15 mg
Incyte Biosciences
International Sàrl
B
FB
G
Balversa 3 mg
56
PR
PR
k.A.
Coated tablets: Erdafitinibum 3 mg
Janssen-Cilag AG
A
FB
G
Balversa 3 mg
84
PR
PR
k.A.
Coated tablets: Erdafitinibum 3 mg
Janssen-Cilag AG
A
FB
G
Balversa 4 mg
28
PR
PR
k.A.
Coated tablets: Erdafitinibum 4 mg
Janssen-Cilag AG
A
FB
G
Balversa 4 mg
56
PR
PR
k.A.
Coated tablets: Erdafitinibum 4 mg
Janssen-Cilag AG
A
FB
G
Balversa 5 mg
28
PR
PR
k.A.
Coated tablets: Erdafitinibum 5 mg
Janssen-Cilag AG
A
FB
G
IP
CI
Dapagliflozin Devatis 5 mg
28
PR
PR
k.A.
Coated tablets: Dapagliflozinum 5 mg
Devatis AG
B
FB
G
IP
CI
Dapagliflozin Devatis 5 mg
98
PR
PR
k.A.
Coated tablets: Dapagliflozinum 5 mg
Devatis AG
B
FB
G
IP
Dapagliflozin Devatis 10 mg
28
PR
PR
k.A.
Coated tablets: Dapagliflozinum 10 mg
Devatis AG
B
FB
G
IP
Dapagliflozin Devatis 10 mg
98
PR
PR
k.A.
Coated tablets: Dapagliflozinum 10 mg
Devatis AG
B
FB
G
Dasatinib Accord 20 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 20 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 50 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 50 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 70 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 70 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 100 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 100 mg
Accord Healthcare AG
A
FB
G
Dasatinib Accord 140 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 140 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 12.5 mg
14
PR
PR
k.A.
Coated tablets: Eltrombopagum 12.5 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 25 mg
14
PR
PR
k.A.
Coated tablets: Eltrombopagum 25 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 25 mg
28
PR
PR
k.A.
Coated tablets: Eltrombopagum 25 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 50 mg
14
PR
PR
k.A.
Coated tablets: Eltrombopagum 50 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 50 mg
28
PR
PR
k.A.
Coated tablets: Eltrombopagum 50 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 75 mg
28
PR
PR
k.A.
Coated tablets: Eltrombopagum 75 mg
Accord Healthcare AG
A
FB
G
IP
CI
Itovebi 3 mg
28
PR
PR
k.A.
Coated tablets: Inavolisibum 3 mg
Roche Pharma
(Schweiz) AG
A
FB
G
IP
Itovebi 9 mg
28
PR
PR
k.A.
Coated tablets: Inavolisibum 9 mg
Roche Pharma
(Schweiz) AG
A
FB
G
Liberelle
21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Exeltis Suisse SA
B
FB
G
Liberelle
3 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Exeltis Suisse SA
B
FB
G
Liberelle
6 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Coated tablets: 2 Active Agents
Exeltis Suisse SA
B
FB
G
Panadol Trio 250 mg / 250 mg / 65 mg
10
PR
PR
k.A.
Coated tablets: 3 Active Agents
Haleon Schweiz AG
B
FB
G
CM
Doxycycline Biovis
10
PR
PR
k.A.
Capsules: Doxycyclinum 100 mg
Biovis Life Sciences SA
A
FB
G
CM
Doxycycline Biovis
50
PR
PR
k.A.
Capsules: Doxycyclinum 100 mg
Biovis Life Sciences SA
A
FB
G
Rivaroxaban-Mepha 10 mg
10
PR
PR
k.A.
Capsules: Rivaroxabanum 10 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 10 mg
30
PR
PR
k.A.
Capsules: Rivaroxabanum 10 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 10 mg
98
PR
PR
k.A.
Capsules: Rivaroxabanum 10 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 15 mg
10
PR
PR
k.A.
Capsules: Rivaroxabanum 15 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 15 mg
14
PR
PR
k.A.
Capsules: Rivaroxabanum 15 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 15 mg
28
PR
PR
k.A.
Capsules: Rivaroxabanum 15 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 15 mg
42
PR
PR
k.A.
Capsules: Rivaroxabanum 15 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 15 mg
98
PR
PR
k.A.
Capsules: Rivaroxabanum 15 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 20 mg
14
PR
PR
k.A.
Capsules: Rivaroxabanum 20 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 20 mg
28
PR
PR
k.A.
Capsules: Rivaroxabanum 20 mg
Mepha Pharma AG
B
FB
G
Rivaroxaban-Mepha 20 mg
98
PR
PR
k.A.
Capsules: Rivaroxabanum 20 mg
Mepha Pharma AG
B
FB
G
IP
CI
Midodrin Leman 2,5 mg
20
PR
PR
k.A.
Tablets: Midodrini Hydrochloridum 2.5 mg
Leman SKL SA
B
FB
G
IP
CI
Midodrin Leman 2,5 mg
50
PR
PR
k.A.
Tablets: Midodrini Hydrochloridum 2.5 mg
Leman SKL SA
B
FB
G
IP
Midodrin Leman 5 mg
20
PR
PR
k.A.
Tablets: Midodrini Hydrochloridum 5 mg
Leman SKL SA
B
FB
G
IP
Midodrin Leman 5 mg
50
PR
PR
k.A.
Tablets: Midodrini Hydrochloridum 5 mg
Leman SKL SA
B
FB
G
IP
CI
Picosulfat Spirig HC 7.5
mg/ml
30 ml
PR
PR
k.A.
Drops: Natrii Picosulfas Monohydricus 7.8 mg/ml
Spirig HealthCare AG
B
FB
G
Ringulette 11.7 mg / 2.7 mg
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Gynial AG
B
FB
G
Ringulette 11.7 mg / 2.7 mg
3
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Gynial AG
B
FB
G
Ringulette 11.7 mg / 2.7 mg
6
PR
PR
k.A.
Vaginal ring: 2 Active Agents
Gynial AG
B
FB
G
IP
CI
Valsarpin 5 mg/160 mg
28
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Lagap SA
B
FB
G
IP
Valsarpin 10 mg/160 mg
28
PR
PR
k.A.
compresse rivestite con film: 2 Active Agents
Lagap SA
B
FB
G
Trimbow 88/5/9
120
PR
PR
k.A.
poudre pour inhalation: 3 Active Agents
Chiesi SA
B
FB
G
Trimbow 88/5/9
360
PR
PR
k.A.
poudre pour inhalation: 3 Active Agents
Chiesi SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home